Treating hypoxemic COVID-19 "ARDS" patients with almitrine: The earlier the better?

Anaesth Crit Care Pain Med. 2020 Aug;39(4):451-452. doi: 10.1016/j.accpm.2020.07.003. Epub 2020 Jul 9.

¹ Intensive Care Division, Geneva University Hospitals, Geneva, Switzerland; Geneva Haemodynamic Research Group, Geneva, Switzerland; Faculty of Medicine, University of Geneva, Geneva, Switzerland. Electronic address: karim.bendjelid@hcuge.ch.
² Intensive Care Division, Geneva University Hospitals, Geneva, Switzerland; Geneva Haemodynamic Research Group, Geneva, Switzerland; Faculty of Medicine, University of Geneva, Geneva, Switzerland.
³ Intensive Care Division, Geneva University Hospitals, Geneva, Switzerland; Geneva Haemodynamic Research Group, Geneva, Switzerland; Faculty of Medicine, University of Geneva, Geneva, Switzerland; Department of Critical Care Medicine, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.

No abstract available

Keywords: Almitrine; COVID-19; Capillary shunt; Hypoxemia.

Publication types